CEN Biotech SG&A Expense (Quarterly) Analysis

CEN Biotech Inc (CENBF)

0.0033 0.00 (0.00%) USD | OTCM | May 01, 16:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2014. Upgrade now.

Date	Value
March 31, 2023	0.478M
December 31, 2022	0.6284M
September 30, 2022	0.6222M
June 30, 2022	0.8425M
March 31, 2022	0.4801M
December 31, 2021	0.807M
September 30, 2021	0.9171M
June 30, 2021	16.26M
March 31, 2021	0.3448M
December 31, 2020	0.3541M
September 30, 2020	0.6323M
June 30, 2020	0.6904M
March 31, 2020	0.5308M
December 31, 2019	0.6608M
September 30, 2019	0.5171M
June 30, 2019	0.9966M
March 31, 2019	0.4052M
December 31, 2018	0.8394M

Date	Value
September 30, 2018	0.6401M
June 30, 2018	0.9687M
March 31, 2018	0.6524M
December 31, 2017	9.993M
September 30, 2017	0.5507M
June 30, 2017	0.6055M
March 31, 2017	0.4647M
December 31, 2016	0.6239M
September 30, 2016	0.1841M
June 30, 2016	0.2409M
March 31, 2016	0.1384M
December 31, 2015	0.5665M
September 30, 2015	0.2004M
June 30, 2015	0.0872M
March 31, 2015	0.3116M
December 31, 2014	0.7116M
September 30, 2014	0.4411M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.3448M

Minimum

Mar 2021

16.26M

Maximum

Jun 2021

1.610M

Average

0.6304M

Median

SG&A Expense (Quarterly) Benchmarks